atorvastatin
Commercial- Indications
- Hyperlipidemia
Company intelligence / Profile preview
Zhejiang Hongyuan Pharmaceutical
Linhai/Taizhou, Zhejiang, Chinahongyuanpharm.com ↗
- Ownership
- Private
- Employees
- ~430
- Development stage
- Commercial
01
Overview
Zhejiang Hongyuan focuses on R&D and manufacturing of APIs, intermediates, and finished drugs for cardiovascular/cerebrovascular diseases and diabetes. Main products include atorvastatin, rosuvastatin calcium, pitavastatin (statins), azilsartan (antihypertensive), empagliflozin/dapagliflozin (SGLT2 inhibitors). The company exports globally to Europe, India, Middle East, Japan/Korea. It holds GMP certification in China/EU/Taiwan among others.
- Therapeutic areas
- CardiovascularEndocrinology
- Modalities
- Small moleculeGeneric drug substances (APIs)Finished dosage forms (FDFs)Intermediates
- Industry
- Chemicals & Materials
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Long-term collaborations with domestic universities/research institutes including Zhejiang University etc.; no major global pharma partnerships disclosed.
Beyond the preview
Go deeper on Zhejiang Hongyuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Hongyuan Pharmaceutical.